BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25324173)

  • 1. Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.
    Igci M; Arslan A; Erturhan S; Igci YZ; Pala E; Gogebakan B; Karakok M; Cakmak EA; Cengiz B
    Mol Biol Rep; 2015 Feb; 42(2):507-16. PubMed ID: 25324173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions.
    Sanchez-Cespedes M; Okami K; Cairns P; Sidransky D
    Genes Chromosomes Cancer; 2000 Mar; 27(3):319-22. PubMed ID: 10679922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
    Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
    Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss of the ING gene family loci is a frequent event in ameloblastoma.
    Borkosky SS; Gunduz M; Beder L; Tsujigiwa H; Tamamura R; Gunduz E; Katase N; Rodriguez AP; Sasaki A; Nagai N; Nagatsuka H
    Oncol Res; 2010; 18(10):509-18. PubMed ID: 20681410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.
    Chen L; Matsubara N; Yoshino T; Nagasaka T; Hoshizima N; Shirakawa Y; Naomoto Y; Isozaki H; Riabowol K; Tanaka N
    Cancer Res; 2001 Jun; 61(11):4345-9. PubMed ID: 11389058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutation, loss of heterozygosity, and expression of tumor suppressor gene ING1 in sporadic colorectal carcinoma].
    Wei JB; Chen LS; Gao F
    Ai Zheng; 2005 Feb; 24(2):141-4. PubMed ID: 15694021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer.
    Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K
    Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel region of deletion on 13q33-q34 in esophageal squamous cell carcinoma.
    Guo GM; Huang XP; Dong JT; Caia Y; Xu X; Han YL; Wu M; Zhan QM; Wang MR
    Oncol Rep; 2005 Dec; 14(6):1639-46. PubMed ID: 16273270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer.
    Hyytinen ER; Frierson HF; Sipe TW; Li CL; Degeorges A; Sikes RA; Chung LW; Dong JT
    Prostate; 1999 Nov; 41(3):190-5. PubMed ID: 10517877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.
    Hara Y; Zheng Z; Evans SC; Malatjalian D; Riddell DC; Guernsey DL; Wang LD; Riabowol K; Casson AG
    Cancer Lett; 2003 Mar; 192(1):109-16. PubMed ID: 12637159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.
    Chen LS; Wei JB; Zhou YC; Zhang S; Liang JL; Cao YF; Tang ZJ; Zhang XL; Gao F
    World J Gastroenterol; 2005 Oct; 11(39):6120-4. PubMed ID: 16273637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutation of ING1 gene in laryngeal squamous cell carcinoma and its association with p33ING1b protein expression].
    Li F; Li J; Sheng H; Dai L; Cheng K; Lin S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 25(21):986-9. PubMed ID: 22260079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function.
    Zeremski M; Hill JE; Kwek SS; Grigorian IA; Gurova KV; Garkavtsev IV; Diatchenko L; Koonin EV; Gudkov AV
    J Biol Chem; 1999 Nov; 274(45):32172-81. PubMed ID: 10542254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ING1 and ING2: multifaceted tumor suppressor genes.
    Guérillon C; Larrieu D; Pedeux R
    Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma.
    Krishnamurthy J; Kannan K; Feng J; Mohanprasad BK; Tsuchida N; Shanmugam G
    Oral Oncol; 2001 Apr; 37(3):222-4. PubMed ID: 11287275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.